Healthcare provider profile · identity verified

Anitha Kolli, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · SPRING HILL, FL · NPI 1497766653

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Anitha Kolli, M.D. received $244.04 in general payments during 2025 across 4 reported records.

SANOFI-AVENTIS U.S. LLC accounted for 48.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Symbicort by this doctor in 2024.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Jardiance by this doctor in 2024.

SANOFI-AVENTIS U.S. LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LANTUS as an associated drug or biological on 12 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Lantus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$244.04

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
SANOFI-AVENTIS U.S. LLC	Unresolved — no canonical attribution shown	$117.68	48.2%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$83.16	34.1%	1	2025
Smith+Nephew, Inc.	Unresolved — no canonical attribution shown	$21.83	8.9%	1	2025
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$21.37	8.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$244.04	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
TZIELD Normalized: tzield	Biological	SANOFI-AVENTIS U.S. LLC	$117.68	1	2025
Source payment records 2025-06-12 · SANOFI-AVENTIS U.S. LLC · $117.68 · Open Payments source
AIRSUPRA Normalized: airsupra	Drug	AstraZeneca Pharmaceuticals LP	$83.16	1	2025
Source payment records 2025-02-20 · AstraZeneca Pharmaceuticals LP · $83.16 · Open Payments source
COLLAGENASE SANTYL Normalized: collagenase santyl	Drug	Smith+Nephew, Inc.	$21.83	1	2025
Source payment records 2025-01-23 · Smith+Nephew, Inc. · $21.83 · Open Payments source
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$21.37	1	2025
Source payment records 2025-02-04 · Boehringer Ingelheim Pharmaceuticals, Inc. · $21.37 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	36 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	36	suppressed by CMS
SANOFI-AVENTIS U.S. LLC Exact reporting entity; no affiliate inference	2025	LANTUS open payments reported associated product	CMS Open Payments — General Payments 12 supporting records · 11 recipient NPIs · example record 1233196856	Lantus · 2024 Exact normalized brand match · 1 Part D row	26	14

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	1007	272
Atorvastatin Calcium	Atorvastatin Calcium	998	341
Amlodipine Besylate	Amlodipine Besylate	724	268
Lisinopril	Lisinopril	556	183
Montelukast Sodium	Montelukast Sodium	555	170
Gabapentin	Gabapentin	541	185
Alprazolam	Alprazolam	450	96
Losartan Potassium	Losartan Potassium	443	155
Furosemide	Furosemide	428	163
Omeprazole	Omeprazole	390	148
Rosuvastatin Calcium	Rosuvastatin Calcium	381	109
Potassium Chloride	Potassium Chloride	380	165
Metformin Hcl	Metformin Hcl	359	112
Tramadol Hcl	Tramadol Hcl	333	108
Azithromycin	Azithromycin	299	225
Eliquis	Apixaban	295	98
Meloxicam	Meloxicam	285	102
Baclofen	Baclofen	272	106
Trazodone Hcl	Trazodone Hcl	268	81
Metoprolol Tartrate	Metoprolol Tartrate	267	98
Simvastatin	Simvastatin	259	81
Atenolol	Atenolol	252	71
Citalopram Hbr	Citalopram Hydrobromide	250	78
Metoprolol Succinate	Metoprolol Succinate	238	93
Clopidogrel	Clopidogrel Bisulfate	231	87
Pantoprazole Sodium	Pantoprazole Sodium	230	94
Alendronate Sodium	Alendronate Sodium	221	68
Tamsulosin Hcl	Tamsulosin Hcl	205	88
Albuterol Sulfate Hfa	Albuterol Sulfate	199	63
Fluticasone Propionate	Fluticasone Propionate	195	85
Sertraline Hcl	Sertraline Hcl	174	54
Hydrochlorothiazide	Hydrochlorothiazide	172	55
Glipizide	Glipizide	164	48
Methylprednisolone	Methylprednisolone	162	128
Ondansetron Hcl	Ondansetron Hcl	161	44
Carvedilol	Carvedilol	157	62
Zolpidem Tartrate	Zolpidem Tartrate	155	52
Mirtazapine	Mirtazapine	143	56
Ezetimibe	Ezetimibe	137	42
Ozempic	Semaglutide	133	24
Glipizide Er	Glipizide	129	41
Buspirone Hcl	Buspirone Hcl	125	46
Doxazosin Mesylate	Doxazosin Mesylate	123	47
Allopurinol	Allopurinol	110	34
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	106	86
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	47
Meclizine Hcl	Meclizine Hcl	102	47
Gemfibrozil	Gemfibrozil	101	33
Famotidine	Famotidine	98	50
Ciprofloxacin Hcl	Ciprofloxacin Hcl	95	73
Lorazepam	Lorazepam	94	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	21
Memantine Hcl	Memantine Hcl	87	21
Quetiapine Fumarate	Quetiapine Fumarate	87	32
Tizanidine Hcl	Tizanidine Hcl	87	31
Midodrine Hcl	Midodrine Hcl	86	48
Escitalopram Oxalate	Escitalopram Oxalate	85	23
Duloxetine Hcl	Duloxetine Hcl	84	33
Finasteride	Finasteride	84	23
Lovastatin	Lovastatin	84	25
Divalproex Sodium	Divalproex Sodium	79	29
Cephalexin	Cephalexin	78	57
Clonazepam	Clonazepam	76	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	75	11
Levetiracetam	Levetiracetam	73	20
Ofloxacin	Ofloxacin	72	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	12
Amiodarone Hcl	Amiodarone Hcl	69	26
Donepezil Hcl	Donepezil Hcl	65	26
Pravastatin Sodium	Pravastatin Sodium	65	23
Synthroid	Levothyroxine Sodium	65	18
Fenofibrate	Fenofibrate	64	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	18
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	63	30
Fenofibrate	Fenofibrate Nanocrystallized	62	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	21
Januvia	Sitagliptin Phosphate	60	15
Nystatin	Nystatin	60	22
Oxycodone Hcl	Oxycodone Hcl	58	11
Prednisone	Prednisone	58	36
Sucralfate	Sucralfate	56	35
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	55	24
Doxycycline Hyclate	Doxycycline Hyclate	53	43
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	33
Oxybutynin Chloride	Oxybutynin Chloride	51	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	18
Ranolazine Er	Ranolazine	50	suppressed
Ropinirole Hcl	Ropinirole Hcl	50	13
Glimepiride	Glimepiride	49	19
Spironolactone	Spironolactone	49	33
Lamotrigine	Lamotrigine	48	13
Lactulose	Lactulose	46	12
Pregabalin	Pregabalin	46	19
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Mounjaro	Tirzepatide	43	suppressed
Bupropion Hcl	Bupropion Hcl	42	11
Diltiazem Hcl	Diltiazem Hcl	42	20
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Ibuprofen	Ibuprofen	40	15
Carbidopa-Levodopa	Carbidopa/Levodopa	39	11
Propranolol Hcl	Propranolol Hcl	39	16
Temazepam	Temazepam	39	15
Warfarin Sodium	Warfarin Sodium	39	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	38	31
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	37	13
Esomeprazole Magnesium	Esomeprazole Magnesium	37	13
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Glatiramer Acetate	Glatiramer Acetate	36	suppressed
Jardiance	Empagliflozin	36	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	36	12
Triamcinolone Acetonide	Triamcinolone Acetonide	36	14
Hydrocortisone	Hydrocortisone	35	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	11
Metronidazole	Metronidazole	33	33
Oxybutynin Chloride Er	Oxybutynin Chloride	33	12
Levofloxacin	Levofloxacin	32	25
Xarelto	Rivaroxaban	32	16
Amoxicillin	Amoxicillin	31	19
Bupropion Xl	Bupropion Hcl	31	suppressed
Celecoxib	Celecoxib	31	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	31	21
Anastrozole	Anastrozole	30	suppressed
Ceftriaxone	Ceftriaxone Sodium	30	18
Sildenafil Citrate	Sildenafil Citrate	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Breyna	Budesonide/Formoterol Fumarate	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	13
Irbesartan	Irbesartan	29	suppressed
Mupirocin	Mupirocin	28	21
Cefdinir	Cefdinir	27	27
Fluconazole	Fluconazole	27	17
Hydralazine Hcl	Hydralazine Hcl	27	18
Methocarbamol	Methocarbamol	27	16
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	16
Lantus	Insulin Glargine,hum.Rec.Anlog	26	14
Cholestyramine	Cholestyramine (With Sugar)	25	19
Colchicine	Colchicine	25	suppressed
Diazepam	Diazepam	25	suppressed
Primidone	Primidone	25	suppressed
Topiramate	Topiramate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	20
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Benzonatate	Benzonatate	23	22
Latanoprost	Latanoprost	23	11
Enalapril Maleate	Enalapril Maleate	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Bumetanide	Bumetanide	21	15
Digoxin	Digoxin	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Lidocaine Hcl	Lidocaine Hcl	21	12
Ventolin Hfa	Albuterol Sulfate	21	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Ondansetron Odt	Ondansetron	20	11
Risperidone	Risperidone	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Estradiol	Estradiol	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Zafirlukast	Zafirlukast	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Ammonium Lactate	Ammonium Lactate	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Ciloxan	Ciprofloxacin Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Phenytoin	Phenytoin	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Cefepime Hcl	Cefepime Hcl	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Nitroglycerin	Nitroglycerin	15	12
Permethrin	Permethrin	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Acetic Acid	Acetic Acid	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Letrozole	Letrozole	12	suppressed
Naproxen	Naproxen	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Nystop	Nystatin	12	suppressed
Rytary	Carbidopa/Levodopa	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Clonidine	Clonidine	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$244.04 · 4 records	SANOFI-AVENTIS U.S. LLC	AIRSUPRA, COLLAGENASE SANTYL, JARDIANCE, TZIELD	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error